Ahead of this year's CTO Connect 2021 conference, we are running a Case Competition open to everyone. Entering the competition is easy and takes just a few minutes. Here's how...
Digoxin improved some measures of quality of life at 12 months and was associated with greater reductions in NYHA class and NT-proBNP. Digoxin was also associated with fewer adverse events compared with beta-blockers.